静脈内溶液（コロイド）のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Intravenous Solutions (Colloids) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16444 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

静脈内溶液（コロイド）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の静脈内溶液（コロイド）の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の静脈内溶液（コロイド）の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 静脈内溶液（コロイド）市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・末梢非経口栄養、総非経口栄養 用途別セグメントは次のように区分されます。 ・病院・クリニック、外来、在宅医療 世界の静脈内溶液（コロイド）市場の主要な市場プレーヤーは以下のとおりです。 ・ICU Medical Inc.、B. Braun Melsungen AG、Fresenius Kabi AG、Baxter、Amanta Healthcare、Terumo Medical Corporation、Grifols S.A. 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、静脈内溶液（コロイド）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な静脈内溶液（コロイド）メーカーの企業概要、2019年～2021年までの静脈内溶液（コロイド）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な静脈内溶液（コロイド）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別静脈内溶液（コロイド）の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの静脈内溶液（コロイド）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での静脈内溶液（コロイド）市場予測を収録しています。 ・第12、13、14章では、静脈内溶液（コロイド）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：ICU Medical Inc.、B. Braun Melsungen AG、Fresenius Kabi AG、Baxter、Amanta Healthcare、Terumo Medical Corporation、Grifols S.A. ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：末梢非経口栄養、総非経口栄養 ・用途別分析2016年-2026年：病院・クリニック、外来、在宅医療 ・静脈内溶液（コロイド）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・静脈内溶液（コロイド）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・静脈内溶液（コロイド）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・静脈内溶液（コロイド）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・静脈内溶液（コロイド）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Intravenous Solutions (Colloids) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Intravenous Solutions (Colloids) size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Intravenous Solutions (Colloids) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Intravenous Solutions (Colloids) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Market segment by Application can be divided into
Hospital and Clinics
Ambulatory
Home Care

The key market players for global Intravenous Solutions (Colloids) market are listed below:
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Intravenous Solutions (Colloids) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Solutions (Colloids), with price, sales, revenue and global market share of Intravenous Solutions (Colloids) from 2019 to 2021.
Chapter 3, the Intravenous Solutions (Colloids) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Solutions (Colloids) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Intravenous Solutions (Colloids) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Intravenous Solutions (Colloids) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Intravenous Solutions (Colloids) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Solutions (Colloids) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Solutions (Colloids) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global Intravenous Solutions (Colloids) Market Size & Forecast
1.4.1 Global Intravenous Solutions (Colloids) Sales in Value (2016-2026))
1.4.2 Global Intravenous Solutions (Colloids) Sales in Volume (2016-2026)
1.4.3 Global Intravenous Solutions (Colloids) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Intravenous Solutions (Colloids) Production Capacity Analysis
1.5.1 Global Intravenous Solutions (Colloids) Total Production Capacity (2016-2026)
1.5.2 Global Intravenous Solutions (Colloids) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous Solutions (Colloids) Market Drivers
1.6.2 Intravenous Solutions (Colloids) Market Restraints
1.6.3 Intravenous Solutions (Colloids) Trends Analysis
2 Manufacturers Profiles
2.1 ICU Medical Inc.
2.1.1 ICU Medical Inc. Details
2.1.2 ICU Medical Inc. Major Business
2.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Product and Services
2.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 B. Braun Melsungen AG
2.2.1 B. Braun Melsungen AG Details
2.2.2 B. Braun Melsungen AG Major Business
2.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product and Services
2.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Fresenius Kabi AG
2.3.1 Fresenius Kabi AG Details
2.3.2 Fresenius Kabi AG Major Business
2.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Product and Services
2.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Intravenous Solutions (Colloids) Product and Services
2.4.4 Baxter Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Amanta Healthcare
2.5.1 Amanta Healthcare Details
2.5.2 Amanta Healthcare Major Business
2.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Product and Services
2.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Terumo Medical Corporation
2.6.1 Terumo Medical Corporation Details
2.6.2 Terumo Medical Corporation Major Business
2.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Product and Services
2.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Grifols S.A.
2.7.1 Grifols S.A. Details
2.7.2 Grifols S.A. Major Business
2.7.3 Grifols S.A. Intravenous Solutions (Colloids) Product and Services
2.7.4 Grifols S.A. Intravenous Solutions (Colloids) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Intravenous Solutions (Colloids) Sales by Manufacturer
3.1 Global Intravenous Solutions (Colloids) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Intravenous Solutions (Colloids) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Intravenous Solutions (Colloids)
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Solutions (Colloids) Manufacturer Market Share
3.4.2 Top 6 Intravenous Solutions (Colloids) Manufacturer Market Share
3.5 Global Intravenous Solutions (Colloids) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Intravenous Solutions (Colloids) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous Solutions (Colloids) Market Size by Region
4.1.1 Global Intravenous Solutions (Colloids) Sales in Volume by Region (2016-2026)
4.1.2 Global Intravenous Solutions (Colloids) Revenue by Region (2016-2026)
4.2 North America Intravenous Solutions (Colloids) Revenue (2016-2026)
4.3 Europe Intravenous Solutions (Colloids) Revenue (2016-2026)
4.4 Asia-Pacific Intravenous Solutions (Colloids) Revenue (2016-2026)
4.5 South America Intravenous Solutions (Colloids) Revenue (2016-2026)
4.6 Middle East and Africa Intravenous Solutions (Colloids) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Intravenous Solutions (Colloids) Sales in Volume by Type (2016-2026)
5.2 Global Intravenous Solutions (Colloids) Revenue by Type (2016-2026)
5.3 Global Intravenous Solutions (Colloids) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Intravenous Solutions (Colloids) Sales in Volume by Application (2016-2026)
6.2 Global Intravenous Solutions (Colloids) Revenue by Application (2016-2026)
6.3 Global Intravenous Solutions (Colloids) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous Solutions (Colloids) Sales by Type (2016-2026)
7.2 North America Intravenous Solutions (Colloids) Sales by Application (2016-2026)
7.3 North America Intravenous Solutions (Colloids) Market Size by Country
7.3.1 North America Intravenous Solutions (Colloids) Sales in Volume by Country (2016-2026)
7.3.2 North America Intravenous Solutions (Colloids) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous Solutions (Colloids) Sales by Type (2016-2026)
8.2 Europe Intravenous Solutions (Colloids) Sales by Application (2016-2026)
8.3 Europe Intravenous Solutions (Colloids) Market Size by Country
8.3.1 Europe Intravenous Solutions (Colloids) Sales in Volume by Country (2016-2026)
8.3.2 Europe Intravenous Solutions (Colloids) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Intravenous Solutions (Colloids) Sales by Type (2016-2026)
9.2 Asia-Pacific Intravenous Solutions (Colloids) Sales by Application (2016-2026)
9.3 Asia-Pacific Intravenous Solutions (Colloids) Market Size by Region
9.3.1 Asia-Pacific Intravenous Solutions (Colloids) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Intravenous Solutions (Colloids) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Intravenous Solutions (Colloids) Sales by Type (2016-2026)
10.2 South America Intravenous Solutions (Colloids) Sales by Application (2016-2026)
10.3 South America Intravenous Solutions (Colloids) Market Size by Country
10.3.1 South America Intravenous Solutions (Colloids) Sales in Volume by Country (2016-2026)
10.3.2 South America Intravenous Solutions (Colloids) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous Solutions (Colloids) Sales by Type (2016-2026)
11.2 Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2016-2026)
11.3 Middle East & Africa Intravenous Solutions (Colloids) Market Size by Country
11.3.1 Middle East & Africa Intravenous Solutions (Colloids) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Intravenous Solutions (Colloids) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Intravenous Solutions (Colloids) Typical Distributors
12.3 Intravenous Solutions (Colloids) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Intravenous Solutions (Colloids) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Intravenous Solutions (Colloids) Revenue by Application, (USD Million), 2021-2026
Table 3. ICU Medical Inc. Basic Information, Manufacturing Base and Competitors
Table 4. ICU Medical Inc. Major Business
Table 5. ICU Medical Inc. Intravenous Solutions (Colloids) Product and Services
Table 6. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 8. B. Braun Melsungen AG Major Business
Table 9. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product and Services
Table 10. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 12. Fresenius Kabi AG Major Business
Table 13. Fresenius Kabi AG Intravenous Solutions (Colloids) Product and Services
Table 14. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Baxter Basic Information, Manufacturing Base and Competitors
Table 16. Baxter Major Business
Table 17. Baxter Intravenous Solutions (Colloids) Product and Services
Table 18. Baxter Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Amanta Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Amanta Healthcare Major Business
Table 21. Amanta Healthcare Intravenous Solutions (Colloids) Product and Services
Table 22. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Terumo Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Terumo Medical Corporation Major Business
Table 25. Terumo Medical Corporation Intravenous Solutions (Colloids) Product and Services
Table 26. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Grifols S.A. Basic Information, Manufacturing Base and Competitors
Table 28. Grifols S.A. Major Business
Table 29. Grifols S.A. Intravenous Solutions (Colloids) Product and Services
Table 30. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Intravenous Solutions (Colloids) Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Intravenous Solutions (Colloids) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Intravenous Solutions (Colloids), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Intravenous Solutions (Colloids) Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Intravenous Solutions (Colloids) Production Site of Key Manufacturer
Table 36. Intravenous Solutions (Colloids) New Entrant and Capacity Expansion Plans
Table 37. Intravenous Solutions (Colloids) Mergers & Acquisitions in the Past Five Years
Table 38. Global Intravenous Solutions (Colloids) Sales by Region (2016-2021e) & (K Units)
Table 39. Global Intravenous Solutions (Colloids) Sales by Region (2021-2026) & (K Units)
Table 40. Global Intravenous Solutions (Colloids) Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Intravenous Solutions (Colloids) Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Intravenous Solutions (Colloids) Sales by Type (2016-2021e) & (K Units)
Table 43. Global Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units)
Table 44. Global Intravenous Solutions (Colloids) Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Intravenous Solutions (Colloids) Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Intravenous Solutions (Colloids) Price by Type (2016-2021e) & (USD/Unit)
Table 47. Global Intravenous Solutions (Colloids) Price by Type (2021-2026) & (USD/Unit)
Table 48. Global Intravenous Solutions (Colloids) Sales by Application (2016-2021e) & (K Units)
Table 49. Global Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units)
Table 50. Global Intravenous Solutions (Colloids) Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Intravenous Solutions (Colloids) Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Intravenous Solutions (Colloids) Price by Application (2016-2021e) & (USD/Unit)
Table 53. Global Intravenous Solutions (Colloids) Price by Application (2021-2026) & (USD/Unit)
Table 54. North America Intravenous Solutions (Colloids) Sales by Country (2016-2021e) & (K Units)
Table 55. North America Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units)
Table 56. North America Intravenous Solutions (Colloids) Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Intravenous Solutions (Colloids) Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Intravenous Solutions (Colloids) Sales by Type (2016-2021e) & (K Units)
Table 59. North America Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units)
Table 60. North America Intravenous Solutions (Colloids) Sales by Application (2016-2021e) & (K Units)
Table 61. North America Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units)
Table 62. Europe Intravenous Solutions (Colloids) Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units)
Table 64. Europe Intravenous Solutions (Colloids) Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Intravenous Solutions (Colloids) Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Intravenous Solutions (Colloids) Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units)
Table 68. Europe Intravenous Solutions (Colloids) Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Intravenous Solutions (Colloids) Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Intravenous Solutions (Colloids) Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Intravenous Solutions (Colloids) Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Intravenous Solutions (Colloids) Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Intravenous Solutions (Colloids) Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Intravenous Solutions (Colloids) Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units)
Table 78. South America Intravenous Solutions (Colloids) Sales by Country (2016-2021e) & (K Units)
Table 79. South America Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units)
Table 80. South America Intravenous Solutions (Colloids) Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Intravenous Solutions (Colloids) Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Intravenous Solutions (Colloids) Sales by Type (2016-2021e) & (K Units)
Table 83. South America Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units)
Table 84. South America Intravenous Solutions (Colloids) Sales by Application (2016-2021e) & (K Units)
Table 85. South America Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Intravenous Solutions (Colloids) Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Intravenous Solutions (Colloids) Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Intravenous Solutions (Colloids) Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Intravenous Solutions (Colloids) Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Intravenous Solutions (Colloids) Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Intravenous Solutions (Colloids) Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Intravenous Solutions (Colloids) Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Intravenous Solutions (Colloids) Typical Distributors
Table 97. Intravenous Solutions (Colloids) Typical Customers
List of Figures
Figure 1. Intravenous Solutions (Colloids) Picture
Figure 2. Global Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 3. Peripheral Parenteral Nutrition
Figure 4. Total Parenteral Nutrition
Figure 5. Global Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 6. Hospital and Clinics
Figure 7. Ambulatory
Figure 8. Home Care
Figure 9. Global Intravenous Solutions (Colloids) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Intravenous Solutions (Colloids) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Intravenous Solutions (Colloids) Sales (2016-2026) & (K Units)
Figure 12. Global Intravenous Solutions (Colloids) Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Intravenous Solutions (Colloids) Production Capacity (2016-2026) & (K Units)
Figure 14. Global Intravenous Solutions (Colloids) Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Intravenous Solutions (Colloids) Market Drivers
Figure 16. Intravenous Solutions (Colloids) Market Restraints
Figure 17. Intravenous Solutions (Colloids) Market Trends
Figure 18. Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturer in 2020
Figure 19. Global Intravenous Solutions (Colloids) Revenue Market Share by Manufacturer in 2020
Figure 20. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Intravenous Solutions (Colloids) Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Intravenous Solutions (Colloids) Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2016-2026)
Figure 24. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2016-2026)
Figure 25. North America Intravenous Solutions (Colloids) Revenue (2016-2026) & (USD Million)
Figure 26. Europe Intravenous Solutions (Colloids) Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Intravenous Solutions (Colloids) Revenue (2016-2026) & (USD Million)
Figure 28. South America Intravenous Solutions (Colloids) Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Intravenous Solutions (Colloids) Revenue (2016-2026) & (USD Million)
Figure 30. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2026)
Figure 31. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2016-2026)
Figure 32. Global Intravenous Solutions (Colloids) Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2026)
Figure 34. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2016-2026)
Figure 35. Global Intravenous Solutions (Colloids) Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2026)
Figure 37. North America Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2026)
Figure 38. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2016-2026)
Figure 39. North America Intravenous Solutions (Colloids) Revenue Market Share by Country (2016-2026)
Figure 40. United States Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2026)
Figure 44. Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2026)
Figure 45. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2016-2026)
Figure 46. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2016-2026)
Figure 47. Germany Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Intravenous Solutions (Colloids) Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region (2016-2026)
Figure 56. China Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2026)
Figure 63. South America Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2026)
Figure 64. South America Intravenous Solutions (Colloids) Sales Market Share by Country (2016-2026)
Figure 65. South America Intravenous Solutions (Colloids) Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Intravenous Solutions (Colloids) Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Intravenous Solutions (Colloids) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---